Orion
§ CompareCellular & mitochondrial research compounds

MOTS-c vs NAD+

MOTS-c is a mitochondrial-derived 16-amino-acid peptide. NAD+ is a small-molecule coenzyme central to cellular energy metabolism. Both are studied in mitochondrial-function research but represent very different chemistry.

Research Use Only

Comparison information is provided for in-vitro research reference only. Orion compounds are not FDA-approved and are not for human consumption.

MOTS-cNAD+
CAS Number1627580-64-653-84-9
Molecular Weight2174.67 g/mol663.43 g/mol
Sequence
Purity (spec)98.9%99.1%
Size10mg100mg
Half-Life (lit.)15 min (lit. 0.15h–0.5h)12 min (lit. 0.1h–0.5h)
Single price$26.99$17.99
10-pack/vial$20.24$13.49
In stock?YesYes

FAQ

What's the chemical difference between MOTS-c and NAD+?

MOTS-c (CAS 1627580-64-6, MW 2174.67 g/mol) and NAD+ (CAS 53-84-9, MW 663.43 g/mol) are distinct compounds. MOTS-c is a mitochondrial-derived 16-amino-acid peptide. NAD+ is a small-molecule coenzyme central to cellular energy metabolism. Both are studied in mitochondrial-function research but represent very different chemistry.

Which is more commonly used in research?

Both MOTS-c and NAD+ appear extensively in Cellular & mitochondrial research compounds literature. Comparative-mechanism studies frequently use them as paired references. Selection between them depends on the receptor coverage, kinetics, and assay system of the planned experiment.

What purity does Orion ship for each?

MOTS-c ships at 98.9%. NAD+ ships at 99.1%. Each batch is independently tested by reversed-phase HPLC and confirmed by mass spectrometry against the theoretical molecular weight. Every order ships with a batch-specific Certificate of Analysis.

Are these for human use?

No. All Orion research compounds are for in-vitro laboratory research only. They are not FDA-approved for any therapeutic, diagnostic, or clinical use, and they are not for human consumption.

Other comparisons